CA1253438A - Etage de turbine a vapeur - Google Patents

Info

Publication number

CA1253438A

CA1253438A CA000492196A CA492196A CA1253438A CA 1253438 A CA1253438 A CA 1253438A CA 000492196 A CA000492196 A CA 000492196A CA 492196 A CA492196 A CA 492196A CA 1253438 A CA1253438 A CA 1253438A

Authority

CA

Canada

Prior art keywords

buckets

stage

rib

nozzle

turbine

Prior art date

1985-10-03

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 238000005192 partition Methods 0.000 claims abstract description 105
• 239000012530 fluid Substances 0.000 claims description 17
• 239000000463 material Substances 0.000 claims description 3
• 238000007789 sealing Methods 0.000 abstract description 17
• 230000008878 coupling Effects 0.000 abstract description 4
• 238000010168 coupling process Methods 0.000 abstract description 4
• 238000005859 coupling reaction Methods 0.000 abstract description 4
• RLQJEEJISHYWON-UHFFFAOYSA-N flonicamid Chemical compound FC(F)(F)C1=CC=NC=C1C(=O)NCC#N RLQJEEJISHYWON-UHFFFAOYSA-N 0.000 abstract description 2
• 238000004326 stimulated echo acquisition mode for imaging Methods 0.000 abstract 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
• 238000011144 upstream manufacturing Methods 0.000 description 15
• 238000013461 design Methods 0.000 description 11
• 230000003134 recirculating effect Effects 0.000 description 8
• 230000035939 shock Effects 0.000 description 7
• 230000007423 decrease Effects 0.000 description 5
• 230000003247 decreasing effect Effects 0.000 description 5
• 230000036961 partial effect Effects 0.000 description 5
• 230000007704 transition Effects 0.000 description 5
• 238000000926 separation method Methods 0.000 description 3
• 230000015572 biosynthetic process Effects 0.000 description 2
• 238000006243 chemical reaction Methods 0.000 description 2
• 230000000694 effects Effects 0.000 description 2
• 230000006872 improvement Effects 0.000 description 2
• 238000004519 manufacturing process Methods 0.000 description 2
• 238000012986 modification Methods 0.000 description 2
• 230000004048 modification Effects 0.000 description 2
• 239000002245 particle Substances 0.000 description 2
• 230000002829 reductive effect Effects 0.000 description 2
• SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 1
• 241000937413 Axia Species 0.000 description 1
• 102100034742 Rotatin Human genes 0.000 description 1
• 101710200213 Rotatin Proteins 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 230000003466 anti-cipated effect Effects 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 1
• 239000011248 coating agent Substances 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 238000009833 condensation Methods 0.000 description 1
• 230000005494 condensation Effects 0.000 description 1
• 238000001816 cooling Methods 0.000 description 1
• 239000000498 cooling water Substances 0.000 description 1
• 238000013016 damping Methods 0.000 description 1
• 238000010586 diagram Methods 0.000 description 1
• 235000012489 doughnuts Nutrition 0.000 description 1
• 150000002085 enols Chemical class 0.000 description 1
• 230000003628 erosive effect Effects 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 235000003642 hunger Nutrition 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• 230000002427 irreversible effect Effects 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
• 229910052753 mercury Inorganic materials 0.000 description 1
• 238000000034 method Methods 0.000 description 1
• 230000008520 organization Effects 0.000 description 1
• 229920000136 polysorbate Polymers 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 230000000063 preceeding effect Effects 0.000 description 1
• MKFWBVKQDGNXDW-SPIKMXEPSA-N proglumetacin dimaleate Chemical compound OC(=O)\C=C/C(O)=O.OC(=O)\C=C/C(O)=O.C=1C=CC=CC=1C(=O)NC(C(=O)N(CCC)CCC)CCC(=O)OCCCN(CC1)CCN1CCOC(=O)CC(C1=CC(OC)=CC=C11)=C(C)N1C(=O)C1=CC=C(Cl)C=C1 MKFWBVKQDGNXDW-SPIKMXEPSA-N 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 230000001932 seasonal effect Effects 0.000 description 1
• 239000007787 solid Substances 0.000 description 1
• 230000037351 starvation Effects 0.000 description 1
• 229910000601 superalloy Inorganic materials 0.000 description 1
• 238000012360 testing method Methods 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1

Cited By (2)